How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold
BioTalk Unzipped18 Marras 2024

How AI is Transforming Drug Development: Reflections from AAPS - PharmSci 360 with Dr. Mark Arnold

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35 years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.


01:05 - Career Reflections and Contributions to Drug Development

05:28 - Understanding the Integration of Drug Development

09:30 - What Would You Change? Embracing Career Risks in Pharma

11:32 - Navigating Career Paths: Small vs. Large Companies

16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer?

23:28 - The Role of AI in Drug Development

31:13 - Encouraging Innovation in a Regulated Industry


Follow Mark, Chad and Gregory:

Please donate to: Samaritan’s Purse

https://www.samaritanspurse.org/

Mark Arnold - https://www.linkedin.com/in/markearnoldphd/

Blog - https://bioanalysisandbiomarkers.blogspot.com/

Dr. Chad Briscoe - https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/


Gregory Austin - https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /


BioTalk Unzipped on LinkedIn - https://www.linkedin.com/company/biotalk-unzipped/


New News Story:


Two articles on finding 1000’s of dark matter RNA viruses:


Image Credits


Jaksot(41)

How AI is Helping Diagnose Disease with Chuck Piccirillo

How AI is Helping Diagnose Disease with Chuck Piccirillo

Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric soluti...

2 Elo 202438min

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom w...

15 Heinä 202438min

Amyloidosis Exposed: New Hope with Dr. Vick

Amyloidosis Exposed: New Hope with Dr. Vick

Summary Dr. Andy Vick discusses his work at Attralus Therapeutics, a biotech company focused on developing treatments for systemic amyloidosis. He explains the etiology of the disease and how Attralus...

1 Heinä 202440min

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s Summary In this conversation, Dr. Jonathan Hill discusses his work in nanopore sequencing-based technology and its applications in genetic and epigenetic rese...

1 Kesä 202430min

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke Summary In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data...

15 Touko 202435min

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Summary In this episode of BioTalk Unzipped, the hosts discuss the applications and ethical concerns surrounding organoids, which are 3D cell clusters that mimic the features of full-sized organs. The...

1 Touko 202434min

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature o...

15 Huhti 202436min

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner Summary In this episode, the hosts welcome Scott Schliebner as their guest and kick off with a charitable act, donating to Rare Givers. They d...

1 Huhti 202436min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
herrasmieshakkerit
rss-rahamania
ostan-asuntoja-podcast
rss-doulapodi
rss-sami-miettinen-neuvottelija
rahapuhetta
rss-lahtijat
rss-paasipodi
juristipodi
rss-sisalto-kuntoon
inderespodi
pomojen-suusta
yrittaja
rss-uskalla-yrittaa
rss-laakispodi
rss-bisnesta-bebeja